Invyncible Review

What Invyncible charges

• NAD+: $192 — the current price against a struck-through $240.00 anchor, with a quantity selector and NO billing period or supply length stated anywhere on the page
• Sermorelin: $179.10 — the current price against a struck-through $199.00 anchor for the 9 mg presentation, with NO billing period or supply length stated anywhere on the page
• Glutathione: $88 — the current price against a struck-through $110.00 anchor; the page offers a 10 mL and a 30 mL option under one displayed figure and does not say which the figure belongs to, and adds "Refrigeration required. Must ship overnight."

The pharmacy question, answered with a table

A page linked from the navigation of every product page lists the pharmacies in its network. Not a category, not a class — six facilities by name, each with a street address, a phone number and a link to its own site.

The page goes further. It says patients may choose where a prescription is sent, may request a copy of the prescription, and may nominate a compounding pharmacy that is not on the list by supplying its name, address and phone number during intake.

It also warns that price, availability, shipping time and fulfilment may vary at a pharmacy outside the network, which is an honest caveat rather than a discouragement.

Twelve rows on this roster name a dispensing facility, this one included. Three of those twelve name more than one — nine facilities on one row, seven on another, and six here. What this page adds to the list is the sentence saying the choice is the patient's, and that a facility outside the list may be nominated during intake.

A coverage exclusion printed where a reader will see it

Every product page carries a notice above the product name saying the product is not available in two named states. It is in visible body text, not a footnote, and it appears before the price.

That is a forty-eight-state seller declaring itself as one. Most sellers in this market either claim every state or say nothing, and a reader discovers the exclusion during intake or after paying.

The exclusion is recorded on this row as a state list of forty-eight rather than as a coverage claim, because a printed exclusion is checkable in a way that a nationwide claim is not.

It is worth noting that this seller was, in an earlier sweep across a sibling network, the company whose unwalked catalogue produced a dozen false claims that it published no prices. It publishes them, plainly, on every product page.

Prices with no period attached to them

Each peptide page shows a current figure against a struck-through higher one, with a quantity selector beside it. No page states a billing period, a supply length, or how many doses an item contains.

So none of these figures can honestly be read as a monthly cost, and this site does not record them as one. A board sorting by monthly price cannot place a per-item charge with no duration against a subscription and call the comparison fair.

The struck-through anchor is its own problem. A price presented as a discount against a higher number is a promotional shape, and a reader has no way to tell whether the higher figure is ever charged.

One page compounds the difficulty by offering two vial sizes — one three times the other — under a single displayed figure, with nothing saying which size the figure belongs to. That ambiguity is recorded on the row rather than resolved by guessing.

The company, and what the pages do and do not claim

The footer of every page names the operating company, states that the brand belongs to it, and gives a street address and a phone number. It also says the affiliated medical practices are independently owned and operated.

The product pages describe each programme as provider-reviewed with individualised prescribing, and say plainly that a prescription is not guaranteed and that a licensed provider decides whether the treatment is appropriate.

One page warns that the product requires refrigeration and must ship overnight. That is a handling fact a buyer needs before ordering, and stating it in the product description rather than in a shipping policy is the right place for it.

No certificate of analysis, purity report or third-party testing claim appears in the text of any page read. Nothing describes lab work as included.

How we verified this

• Loaded three product pages and the pharmacy page with a full browser user-agent, printed the effective URL beside the requested URL on every fetch, and confirmed none redirected.
• Ran a nonsense-path control on the host in the same run and confirmed a not-found response.
• Joined the page's text nodes before matching any price, so a figure split across two elements could not read as an absence.
• Followed the site's own navigation to the pharmacy page rather than trusting the research note, which had recorded no named pharmacy for this seller.
• Read the pharmacy table's contents out of the extracted visible text, confirming each facility has a name, a street address and a phone number rather than counting rows.
• Checked the eleven other rows on this roster that name a facility before writing that this one names the most of them. Two name more, at nine and at seven, so the superlative first drafted here was false and was replaced with the count.
• Took the state exclusion from the notice printed in visible text at the top of each product page, and recorded the state list as fifty minus the two named.
• Recorded every figure as one that is not a monthly rate, because no page states a period, a supply length or a dose count.
• Recorded the two vial sizes offered under one figure as an unresolved ambiguity rather than assigning the figure to either.
• Read the footer of every page for the operating company, the brand relationship and the address.
• Searched the extracted text of every page for certificate, purity and third-party testing language and found none.